Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03228914 · ClinicalTrials.gov registry record · Phase 4
Comparing Blood Loss and Visualization After the Preoperative Use of Topical 0.05% Oxymetazoline Versus 1:1000 Epinephrine Prior to Endoscopic Sinus Surgery
A Phase 4 study of Nasal Polyps and Endoscopic Sinus Surgery, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03228914 is a Phase 4 study of Nasal Polyps and Endoscopic Sinus Surgery that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 20 participants, below the 100-participant average among 7 other Nasal Polyps trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03228914, a Phase 4 study of Nasal Polyps and Endoscopic Sinus Surgery, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effects of Oxymetazoline and Epinephrine (which are 2 different nasal decongestants both of which are routinely used before sinus surgery) on blood loss and the surgeon's view of the surgical field during sinus surgery.
Conditions Studied
Interventions
- DRUG Epinephrine
- DRUG Oxymetazoline
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-06-14 |
| Est. Completion | 2018-08-29 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03228914
The ClinicalTrials.gov registry entry for NCT03228914 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100-participant average among 7 other Nasal Polyps trials with a reported enrollment target (80% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Nasal Polyps appearing as the primary indexed condition, and to 2 interventions - of which Epinephrine is the first listed.
NCT03228914 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03228914 about?
NCT03228914 is a clinical study titled "Comparing Blood Loss and Visualization After the Preoperative Use of Topical 0.05% Oxymetazoline Versus 1:1000 Epinephrine Prior to Endoscopic Sinus Surgery". The purpose of this study is to compare the effects of Oxymetazoline and Epinephrine (which are 2 different nasal decongestants both of which are routinely used before sinus surgery) on blood loss and the surgeon's view of the surgical field during sinus surgery.
What is the current status of trial NCT03228914?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2018-06-14. Estimated completion is 2018-08-29.
What conditions does trial NCT03228914 study?
This clinical trial studies the following conditions: Nasal Polyps, Endoscopic Sinus Surgery.
What interventions are being tested in trial NCT03228914?
The interventions under investigation include: Epinephrine (DRUG), Oxymetazoline (DRUG).
Who is sponsoring clinical trial NCT03228914?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03228914 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nasal Polyps
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
RECRUITING · Phase 4
-
Dupixent Study for Alternate Administration
ACTIVE NOT RECRUITING · Phase 4
-
Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction?
RECRUITING · NA
-
Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease
ACTIVE NOT RECRUITING · Phase 2
-
The Polymerase Chain Reaction (PCR) Analysis of Nasal Polyps for Fungal DNA
COMPLETED · NA
-
Qualitative Analysis of Subject Experience of Nasal Polyps
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.